Leukemia that is located in myeloid tissue.
Chronic leukemia characterized by granular leukocytes; more common in older people.
1The first patient was a 50 years woman with acute myeloid leukemia.
2Three cases of acute myeloid leukemia were reported in the HEC arm.
3Seven patients were studied following bone marrow transplantation for chronic myeloid leukemia.
4Acute myeloid leukemia and myelodysplastic syndromes represented the most common disease indications.
5They include oncology drugs for melanoma, prostate cancer and acute myeloid leukemia.
6Two cases of acute myeloid leukemia were reported with the best available therapy.
7Diseases with the poorest 6-mo prognosis were acute myeloid leukemia and non-Hodgkin lymphoma.
8Differentiation therapy for acute myeloid leukemia uses transcriptional modulators to reprogram cancer cells.
9These results suggest that Zarnestra should be studied further in patients with myeloid leukemia.
10Cutaneous myeloid sarcoma in most cases represents an aggressive manifestation of acute myeloid leukemia.
11Imatinib is now standard therapy for patients with chronic myeloid leukemia in chronic phase.
12These changes in gene expression were related to the differentiation of myeloid leukemia cells.
13Achievement of complete remission is essential for long-term survival of acute myeloid leukemia patients.
14Imatinib mesylate has proven to be the most effective treatment in chronic myeloid leukemia.
15Information about the etiology of childhood myeloid leukemia is limited.
16Current therapies for acute myeloid leukemia are associated with high failure and relapse rates.
Translations for myeloid leukemia